Delivery Order SPE2DB20D3103-SPE2DB21FP9Q9
Award Date
8/19/21
Potential Completion Date
8/20/21
Potential Value
$4.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,647.77, is for the delivery of 4,558,957,998 units of Ramipril 10 mg capsules, which are a cardiovascular medication. The contract is a Firm Fixed Price Delivery Order that has an ultimate completion date of November 2, 2022. It is not designated with any set-aside requirements, indicating...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ramipril 10 mg capsules. The contract, which has a ceiling value of $2,650.03, is a firm fixed-price delivery order with an ultimate completion date of August 26, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation for this award. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, with ID SPE2DB20D3101|SPE2DB22FQTL6, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,485.72 firm fixed-price delivery order is for the supply of 4558302744 - Ramipril 10 mg capsules, with a completion date of September 1, 2022. This award is not designated with any set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical...
This federal contract award, valued at $9,136.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ramipril 10 mg capsules, a medication used to treat high blood pressure and heart failure. The contract has a firm fixed-price pricing type and an ultimate completion date of November 15, 2023. It is not designated as a set-aside contract. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,915.77 delivery order covers the provision of 4,555,850 units of Ramipril 5 mg capsules to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This $999,999,999 IDC...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,558,877,954 Ramipril 5 mg capsules to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $2,358.42, has an ultimate completion date of October 26, 2022. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DB20D1004|SPE2DB22FF1L6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,731.69 delivery order is for the supply of 4556026248 - Ramipril 10 mg capsules, 500s, under a Firm Fixed Price contract. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which...
This federal contract award, valued at $2,003.66, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,556,061,763 units of the prescription medication Ramipril 2.5 mg capsules, with a completion date of January 27, 2022. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major...
This $7,661.05 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,786,561 Ramipril 5 mg capsules, which are prescribed for the treatment of high blood pressure and heart failure. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, that allows the agency to efficiently procure a...
This federal contract award, with a ceiling value of $1,604.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,555,086,379 capsules of the pharmaceutical drug Ramipril 2.5 mg. The contract is a Delivery Order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This...